Forecasting The Future: 12 Analyst Projections For Morgan Stanley

12 analysts have expressed a variety of opinions on Morgan Stanley (NYSE:MS) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $97.92, along with a high estimate of $109.00 and a low estimate of $87.00. This current average represents a 0.99% decrease from the previous average price target of $98.90.

Deciphering Analyst Ratings: An In-Depth Analysis

In examining recent analyst actions, we gain insights into how financial experts perceive Morgan Stanley. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Morgan Stanley's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Morgan Stanley analyst ratings.

Get to Know Morgan Stanley Better

Morgan Stanley's Financial Performance

Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.

Revenue Growth: Morgan Stanley's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 1.12%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.

Net Margin: Morgan Stanley's net margin excels beyond industry benchmarks, reaching 11.5%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Morgan Stanley's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.53%, the company may face hurdles in achieving optimal financial returns.

Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.12%, the company may need to address challenges in generating satisfactory returns from its assets.

Debt Management: Morgan Stanley's debt-to-equity ratio stands notably higher than the industry average, reaching 3.06. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

The Core of Analyst Ratings: What Every Investor Should Know

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.